Author

Alan C. Lunt

St Mary's HospitalORCID 0000-0002-4585-9180Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:benchmarking· 1 Assay:GWAS summary statistics· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Adam S. ButterworthiD· 1 shared Alexis J. BattleiD· 1 shared Amy M. MasoniD· 1 shared Ana I. Hernández CorderoiD· 1 shared Ashis SahaiD· 1 shared Barbara Elizabeth EngelhardtiD· 1 shared Brian JoiD· 1 shared David J. RobertsiD· 1 shared

Activity by Year

2020-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenetic & Genomic Medicine

Adam S. ButterworthORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

ACE inhibition and cardiometabolic risk factors, lung ACE2 and TMPRSS2 gene expression, and plasma ACE2 levels: a Mendelian randomization study

Dipender Gill, Marios Arvanitis, Paul Carter, Ana I. Hernández Cordero, Brian Jo, Ville Karhunen, Susanna C. Larsson, Xuan Li, Sam M. Lockhart, Amy M. Mason, Evanthia E. Pashos, Ashis Saha, Vanessa Y. Tan, Verena Zuber, Yohan Bossé, , Stephen Burgess

This study uses Mendelian randomization to examine if ACE inhibitors or cardiometabolic risk factors affect lung ACE2 and TMPRSS2 expression or plasma ACE2 levels, finding no overall association.

Royal Society Open Science · Nov 1, 2020Peer-reviewedGenetic & Genomic Medicine